Halozyme Therapeutics Inc (HALO)

Debt-to-assets ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Long-term debt	US$ in thousands	1,499,250	1,492,770	787,255	0	383,045
Total assets	US$ in thousands	1,733,270	1,841,510	1,104,430	579,924	565,874
Debt-to-assets ratio		0.86	0.81	0.71	0.00	0.68

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $1,499,250K ÷ $1,733,270K
= 0.86

Halozyme Therapeutics Inc.'s debt-to-assets ratio has shown an increasing trend over the past five years, rising from 0.71 in 2019 to 0.86 in 2023. This indicates that the company has been relying more on debt to finance its assets compared to its equity.

The increasing debt-to-assets ratio suggests that the company's financial risk has also been increasing over the years. A higher ratio implies that a larger portion of the company's assets is financed by debt, which can potentially lead to higher interest expenses and financial obligations.

It is important for investors and stakeholders to closely monitor this trend as a continuously rising debt-to-assets ratio may indicate potential liquidity and solvency risks for the company in the future. It is essential for the company to carefully manage its debt levels to maintain a healthy financial position and avoid potential financial distress.